Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study. | Int J Mol Sci | 2023 | 37298692 | PubTator, text mining | PubMed |
| Comprehensive quantitative sensory testing shows altered sensory function in women with chronic pelvic pain: results from the Translational Research in Pelvic Pain (TRiPP) Study. | Pain | 2023 | 37289573 | PubTator, text mining | PubMed |
| Characterization of metabolism-associated molecular patterns in prostate cancer. | BMC Urol | 2023 | 37280589 | PubTator, text mining | PubMed |
| Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. | Haematologica | 2023 | 37259566 | PubTator, text mining | PubMed |
| An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma. | Respir Res | 2023 | 37259066 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort. | Front Oncol | 2023 | 37234985 | PubTator, text mining | PubMed |
| Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation. | Ann Hematol | 2023 | 37233774 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like. | Sci Rep | 2023 | 37225919 | PubTator, text mining | PubMed |
| A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses. | Sci Transl Med | 2023 | 37224227 | PubTator, text mining | PubMed |
| A Low-power wearable acoustic device for accurate invasive arterial pressure monitoring. | Commun Med (Lond) | 2023 | 37210561 | PubTator, text mining | PubMed |
| Patient safety in prisons: a multi-method analysis of reported incidents in England. | J R Soc Med | 2023 | 37196674 | PubTator, text mining | PubMed |
| Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. | Breast Cancer | 2023 | 37178414 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis. | medRxiv | 2023 | 37163015 | PubTator, text mining | PubMed |
| Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing. | Front Genet | 2023 | 37152992 | PubTator, text mining | PubMed |
| High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma. | Transl Oncol | 2023 | 37149969 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange. | Nat Chem Biol | 2023 | 37142807 | PubTator, text mining | PubMed |
| Intracellular trafficking of HLA-E and its regulation. | J Exp Med | 2023 | 37140910 | PubTator, text mining | PubMed |
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics. | Front Immunol | 2023 | 37138889 | PubTator, text mining | PubMed |
| Identification of immune-associated genes in diagnosing osteoarthritis with metabolic syndrome by integrated bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37138862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=10